Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

An mRNA-based seasonal flu vaccine from Moderna was 27 percent more effective at preventing influenza infections than a ...

The FDA has updated labels on the top two COVID-19 vaccines to warn of a rare heart side effect, mostly seen in young men.

Discover the latest FDA warning updates for COVID vaccines including increased health risks and new restrictions for healthy adults.

U.S. health officials have expanded warnings about a rare heart side effect associated with the two leading COVID-19 vaccines ...

A new warning for the latest round of COVID-19 vaccines from Pfizer and Moderna has been issued by the U.S. Food and Drug ...

The FDA has approved required updates to the labeling of Pfizer’s Comirnaty and Moderna’s Spikevax COVID-19 vaccines to include revised warnings about the risk of myocarditis and pericarditis ...

The Food and Drug Administration has updated its warning labels for the Pfizer and Moderna COVID-19 vaccines, expanding information about a rare but potential heart-related side effect. The updated ...

LONDON, UK AND VANCOUVER, BC / ACCESS Newswire / June 12, 2025 / CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) (“CoTec”) and Mkango Resources Ltd. (AIM:MKA)(TSXV:MKA) (“Mkango”) are pleased to announce ...

Moderna’s stock remains far below its 52-week high of $170.47 and is down more than 65% over the past year. ... Its strong balance sheet and cash reserves offer some buffer, ...

Shares of Moderna (MRNA-2.49%) zoomed as much as 33.3% higher this week, according to data from S&P Global Market Intelligence. The maker of vaccines , including the mRNA vaccine for COVID-19, is ...